CORC  > 四川大学
Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients
Xiaorong Zhong; Zhengwei Dong; Hua Dong; Jiayuan Li; Zuxiang Peng; Ling Deng; Xuehua Zhu; Yun Sun; Xuesong Lu; Fuxiao Shen
刊名PLOS ONE
2016
页码2016
ISSN号1932-6203
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/1841198
专题四川大学
作者单位1.Mem Sloan Kettering Canc Ctr, Dept Pathol,
2.USA
3.AstraZeneca, Asia & Emerging Markets iMed, Shanghai, Peoples R China
4.Sichuan Univ, Lab Mol Diag Canc, State Key Lab Biotherapy, Natl Collaborat Innovat Ctr Biotherapy,West China, Chengdu 610064, Sichuan, Peoples R China
5.Sichuan Univ, Dept Epidemiol & Biostat, West China Sch Publ Hlth, Chengdu 610064, Sichuan, Peoples R China
6.Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610064, Sichuan, Peoples R China
7.York Ave, New York, NY
8.Sichuan Univ, Dept Thyroid & Breast Surg, West China Hosp, Chengdu 610064, Sichuan, Peoples R China
推荐引用方式
GB/T 7714
Xiaorong Zhong,Zhengwei Dong,Hua Dong,et al. Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients[J]. PLOS ONE,2016:2016.
APA Xiaorong Zhong.,Zhengwei Dong.,Hua Dong.,Jiayuan Li.,Zuxiang Peng.,...&Fuxiao Shen.(2016).Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.PLOS ONE,2016.
MLA Xiaorong Zhong,et al."Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients".PLOS ONE (2016):2016.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace